CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q4 2020. The put-call ratio across all filers is 1.58 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $21,008,000 | +44.5% | 621,541 | 0.0% | 2.68% | +41.5% |
| Q1 2021 | $14,538,000 | -31.5% | 621,541 | -15.7% | 1.90% | -38.2% |
| Q4 2020 | $21,237,000 | -15.3% | 737,406 | -40.4% | 3.07% | -12.0% |
| Q3 2020 | $25,070,000 | -32.6% | 1,237,406 | 0.0% | 3.49% | -33.2% |
| Q2 2020 | $37,184,000 | -21.0% | 1,237,406 | -17.4% | 5.22% | -25.6% |
| Q1 2020 | $47,063,000 | -42.8% | 1,497,406 | -14.3% | 7.01% | -83.8% |
| Q4 2019 | $82,320,000 | +454.7% | 1,747,406 | -23.9% | 43.41% | +52.8% |
| Q3 2019 | $14,841,000 | – | 2,297,406 | – | 28.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ponoi II Management, LLC | 1,574,229 | $36,821,000 | 28.20% |
| Ponoi Management, LLC | 1,880,623 | $43,988,000 | 25.87% |
| VR Adviser, LLC | 4,016,873 | $93,955,000 | 10.19% |
| Column Group LLC | 2,626,631 | $61,437,000 | 5.89% |
| Euclidean Capital LLC | 554,325 | $12,966,000 | 4.34% |
| GREAT POINT PARTNERS LLC | 872,415 | $20,406,000 | 4.22% |
| Venrock Management V, LLC | 1,570,058 | $36,724,000 | 3.76% |
| COMMODORE CAPITAL LP | 368,448 | $8,618,000 | 3.43% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 621,541 | $14,538,000 | 1.90% |
| Bain Capital Life Sciences Investors, LLC | 1,400,000 | $32,746,000 | 1.86% |